activins has been researched along with Mesothelioma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koli, K; Myllärniemi, M; Pasternack, A; Ritvos, O; Rönty, M; Sutinen, E; Tamminen, JA; Yin, M | 1 |
Aigner, C; Bendek, M; Berger, W; Brcic, L; Dome, B; Dong, Y; Frauenfelder, T; Ghanim, B; Grusch, M; Hegedus, B; Hoda, MA; Jakopovic, M; Kao, SC; Kirschner, MB; Klepetko, W; Klikovits, T; Laszlo, V; Nguyen-Kim, TD; Opitz, I; Ozsvar, J; Reid, G; Rozsas, A; Samarzija, M; Stockhammer, P; Szirtes, I; van Zandwijk, N; Weder, W | 1 |
Bedeir, A; Berger, W; Catania, A; Dome, B; Eisenbauer, M; Filipits, M; Garay, T; Ghanim, B; Grusch, M; Hegedus, B; Hoda, MA; Kenessey, I; Klepetko, W; Klikovits, T; Lackner, A; Laszlo, V; Münzker, J; Sahin, E; Schelch, K; Setinek, U; Taghavi, S; Török, S | 1 |
3 other study(ies) available for activins and Mesothelioma
Article | Year |
---|---|
Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Activins; Aged; Cell Movement; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Humans; Lung Neoplasms; Male; MAP Kinase Signaling System; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Invasiveness; Smad3 Protein | 2015 |
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Topics: Activins; Aged; Biomarkers, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Prognosis | 2016 |
Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells.
Topics: Activins; Antineoplastic Agents; Blotting, Western; Cell Movement; Cell Proliferation; Cell Survival; Cyclin D; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunohistochemistry; Mesothelioma; Phenotype; Phosphorylation; Pleural Neoplasms; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Smad2 Protein; Tumor Stem Cell Assay; Up-Regulation | 2012 |